Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization

Observational Study of the HemoCept Device During Right Heart Catheterization at Boulder Heart

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07224906

Enrollment

Registered

2025-11-05

Start date

2025-12-01

Completion date

2027-01-01

Last updated

2026-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congestive Heart Failure(CHF), Pulmonary Hypertension, Valve Disease, Heart

Brief summary

The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures. * Subjects can be any gender but must be age 18 or older. * Subject is able and willing to provide informed consent and HIPAA authorization. * Subject is able and willing to meet all study requirements. * Scheduled for a diagnostic right heart catheterization (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible)

Exclusion criteria

* Subject is pregnant, breastfeeding, or intends to become pregnant during this study.

Design outcomes

Primary

Measure	Time frame	Description
Association between device measurements and Pulmonary Capillary Wedge Pressure	Day 1	The correlation of HemoCept device measurements to Pulmonary Capillary Wedge Pressure (PCWP) measured during right heart catheterization.

Countries

United States

Contacts

CONTACTKatharine Adkins

kathari.adkins@bch.org303-442-2395

Outcome results